Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-04

FDA Approved: RIVASTIGMINE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves the original generic application for rivastigmine from Zydus Pharmaceuticals USA Inc., enabling the marketing of rivastigmine products in the Unite…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine (Rivastigmine)

Snippet

ORIG AP for RIVASTIGMINE (RIVASTIGMINE)